Commercialization· September 10, 2026 · 21 min read
ChinaMedGlobal: Checking Access Assumptions in a Licensed Drug Data Room
By Ran Chen#Market Access#Coverage Access#Payer Policy
Topic
AMCP Dossier
AMCP Format for Formulary Submissions, dossier evidence gaps, payer review, and formulary submission quality for specialty drugs.
Evidence· August 29, 2026 · 23 min read
Treatment-Regimen Estimands in FDA Labels: Answering the Real Coverage Question
By Ran Chen#Clinical Evidence#Clinical Trials#FDA
Policy· June 21, 2026 · 5 min read
Building the AMCP dossier: a guide to the version 5.0 format and value evidence template
Pricing & Access· May 22, 2026 · 12 min read
AMCP dossier evidence gaps that weaken payer review for a new specialty drug
By Ran Chen#AMCP Dossier#Formulary#Payer Review
Pipeline· May 22, 2026 · 13 min read
Patient-reported outcome endpoint translation from trial evidence to payer evidence
By Ran Chen#Clinical Evidence#Payer Policy#AMCP Dossier